KLWA
AVNS

Kelly Lawrence W & Associates’s Avanos Medical AVNS Stock Holding History

Kelly Lawrence W & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-137
Closed -$4K – 170
2016
Q2 		$4K Hold
137
– – ﹤0.01% 179
2016
Q1 		$4K Hold
137
– – ﹤0.01% 151
2015
Q4 		$5K Hold
137
– – ﹤0.01% 154
2015
Q3 		$4K Sell
137
-87
-39% -$3.04K ﹤0.01% 137
2015
Q2 		$10K Hold
224
– – ﹤0.01% 128
2015
Q1 		$11K Hold
224
– – ﹤0.01% 112
2014
Q4 		$10K Buy
+224
New +$8.8K ﹤0.01% 119

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Kelly Lawrence W & Associates's AVNS Position: Q3 2016 in Review

Kelly Lawrence W & Associates sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 137 shares — an estimated $4K sold.

Kelly Lawrence W & Associates first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $11K in Q1 2015. 359 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

  • Kelly Lawrence W & Associates reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 137 Avanos Medical shares in Q3 2016, an estimated $4K.
  • Kelly Lawrence W & Associates first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
  • Kelly Lawrence W & Associates's Avanos Medical position peaked at $11K in Q1 2015.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Kelly Lawrence W & Associates's 13F filing for Q3 2016, filed 15 Nov 2016.